Traders should note that Hologic is no longer publicly traded, eliminating liquidity for existing shareholders. The CVR provides potential upside based on future revenue performance, but investors should monitor Hologic's Breast Health segment revenue to assess the likelihood of milestone achievement. The leadership change to Joe Almeida, an experienced MedTech executive, may influence future strategic direction.
Price Chart
Executive Summary
Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal closed at $76 per share in cash plus a contingent value right (CVR) worth up to $3 per share based on future revenue milestones. The company was delisted from Nasdaq, all directors and the CEO resigned, and Joe Almeida was appointed as the new CEO.
Key Financial Metrics
Key Facts
- Hologic was acquired by Blackstone and TPG for $76 per share in cash plus a CVR worth up to $3 per share, totaling up to $79 per share.
- The acquisition closed on April 7, 2026, making Hologic a private company.
- Hologic's stock was delisted from Nasdaq following the acquisition.
- All directors and CEO Stephen MacMillan resigned, with Joe Almeida appointed as the new CEO.
- The CVR payments are contingent on achieving specific revenue milestones for Hologic's Breast Health business in fiscal years 2026 and 2027.
Financial Impact
Total transaction value of up to $79 per share, with $76 in cash and up to $3 in contingent payments. The total cash consideration was approximately $17.3 billion.
Risk Factors
- CVR payments are contingent on future revenue performance and may not be realized.
- Loss of public market liquidity for former shareholders.
- Integration risks under new private ownership and leadership.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-144632 |
| Document: d135035dex32.htm | 0001193125-26-144632 |
| Document: d135035d8k.htm | 0001193125-26-144632 |
| Document: d135035dex991.htm | 0001193125-26-144632 |
| Document: d135035dex31.htm | 0001193125-26-144632 |
| Document: 0001193125-26-144632-index-headers.html | 0001193125-26-144632 |
| Document: 0001193125-26-144632-index.html | 0001193125-26-144632 |
| Document: 0001193125-26-144632.txt | 0001193125-26-144632 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 17, 2026 23w ago | 15-12G | — | awaiting T+1 | — | — |
Apr 13, 2026 24w ago | EFFECT | — | awaiting T+1 | — | — |
Apr 7, 2026 25w ago | 8-K | $76.01 $76.01 | · 0.00% | ▼ −2.54% | — |
Apr 6, 2026 25w ago | 8-K | $76.01 $76.01 | · 0.00% | ▼ −0.06% | — |
Feb 28, 2026 30w ago | Institutional Cluster | $75.45 $75.46 | ▲ +0.01% | ▲ +0.93% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access